Control of energy homeostasis by amylin

[1]  P. Wookey,et al.  CALL FOR PAPERS Integrative and Translational Physiology: Integrative Aspects of Energy Homeostasis and Metabolic Diseases Involvement of the extracellular signal-regulated kinase 1/2 signaling pathway in amylin’s eating inhibitory effect , 2012 .

[2]  T. Lutz,et al.  Amylinergic control of food intake in lean and obese rodents , 2011, Physiology & Behavior.

[3]  R. Seth,et al.  Combined amylin–leptin treatment lowers blood pressure and adiposity in lean and obese rats , 2011, International Journal of Obesity.

[4]  D. Clegg,et al.  Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors , 2011, Acta physiologica.

[5]  T. Lutz,et al.  Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin , 2011, Physiology & Behavior.

[6]  T. Lutz,et al.  Involvement of the histaminergic system in amylin and leptin action , 2011, Appetite.

[7]  L. Asarian,et al.  Estradiol (E2) increases the acute eating-inhibitory effect of amylin in ovariectomized (OVX) rats , 2011, Appetite.

[8]  S. Woods,et al.  Consumption of a high-fat diet induces central insulin resistance independent of adiposity , 2011, Physiology & Behavior.

[9]  T. Lutz.  Amylin may offer (more) help to treat postmenopausal obesity. , 2011, Endocrinology.

[10]  P. Chambon,et al.  Genetic rescue of nonclassical ERα signaling normalizes energy balance in obese Erα-null mutant mice. , 2011, The Journal of clinical investigation.

[11]  B. Apenteng,et al.  Effects of Exendin‐4 Alone and With Peptide YY3–36 on Food Intake and Body Weight in Diet‐Induced Obese Rats , 2011, Obesity.

[12]  D. Parkes,et al.  Enhanced amylin-mediated body weight loss in estradiol-deficient diet-induced obese rats. , 2010, Endocrinology.

[13]  D. Parkes,et al.  “Weighing in” on synergy: Preclinical research on neurohormonal anti-obesity combinations , 2010, Brain Research.

[14]  W. Langhans,et al.  Basal plasma levels of insulin, leptin, ghrelin, and amylin do not signal adiposity in rats recovering from forced overweight. , 2010, Endocrinology.

[15]  S. Woods,et al.  Central amylin acts as an adiposity signal to control body weight and energy expenditure , 2010, Physiology & Behavior.

[16]  B. Roland,et al.  Noradrenergic neurons of the area postrema mediate amylin's hypophagic action. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[17]  D. Parkes,et al.  Insights into amylin–leptin synergy , 2010, Trends in Endocrinology & Metabolism.

[18]  T. Lutz,et al.  Brainstem mechanisms of amylin-induced anorexia , 2010, Physiology & Behavior.

[19]  Z. Knight,et al.  Hyperleptinemia Is Required for the Development of Leptin Resistance , 2010, PloS one.

[20]  T. Lutz,et al.  Identification of central projections from amylin-activated neurons to the lateral hypothalamus , 2010, Brain Research.

[21]  T. Lutz,et al.  Diet-induced obesity, hyperamylinemia and amylin sensitivity , 2010, Appetite.

[22]  T. Lutz,et al.  Amylin induces ERK 1/2 phosphorylation in structures of the AP/NTS-LPB-Ce-BSTL axis , 2010, Appetite.

[23]  P. Wielinga,et al.  Short-term, but not extended, access to palatable diet diminishes amylin responsiveness in rat , 2010, Appetite.

[24]  T. Lutz.  The role of amylin in the control of energy homeostasis. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.

[25]  D. Parkes,et al.  Multi-hormonal weight loss combinations in diet-induced obese rats: Therapeutic potential of cholecystokinin? , 2010, Physiology & Behavior.

[26]  J. Gerich,et al.  Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk , 2010, Vascular health and risk management.

[27]  B. Roland,et al.  Davalintide (AC2307), a novel amylin-mimetic peptide: enhanced pharmacological properties over native amylin to reduce food intake and body weight , 2010, International Journal of Obesity.

[28]  F. Duca,et al.  Differential feeding behavior and neuronal responses to CCK in obesity-prone and -resistant rats , 2010, Brain Research.

[29]  C. Weyer,et al.  Interaction of Leptin and Amylin in the Long‐term Maintenance of Weight Loss in Diet‐induced Obese Rats , 2010, Obesity.

[30]  E. Ravussin,et al.  Enhanced Weight Loss With Pramlintide/Metreleptin: An Integrated Neurohormonal Approach to Obesity Pharmacotherapy , 2009, Obesity.

[31]  Fang Yu,et al.  Palmitic acid mediates hypothalamic insulin resistance by altering PKC-theta subcellular localization in rodents. , 2009, The Journal of clinical investigation.

[32]  T. Lutz,et al.  The ability of amylin to reduce eating depends on the protein content of the diet , 2009, Appetite.

[33]  S. Ogawa,et al.  Divergent effects of estradiol and the estrogen receptor-α agonist PPT on eating and activation of PVN CRH neurons in ovariectomized rats and mice , 2009, Brain Research.

[34]  H. Berthoud,et al.  Phenotype of neurons in the nucleus of the solitary tract that express CCK-induced activation of the ERK signaling pathway. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[35]  B. Levin,et al.  Ventromedial nucleus neurons are less sensitive to leptin excitation in rats bred to develop diet-induced obesity. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[36]  C. Weyer,et al.  Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms. , 2008, Endocrinology.

[37]  S. Woods,et al.  Central control of body weight and appetite. , 2008, The Journal of clinical endocrinology and metabolism.

[38]  P. Sexton,et al.  Receptor activity-modifying proteins differentially modulate the G protein-coupling efficiency of amylin receptors. , 2008, Endocrinology.

[39]  L. Aronne,et al.  Sustained Weight Loss Following 12-Month Pramlintide Treatment as an Adjunct to Lifestyle Intervention in Obesity , 2008, Diabetes Care.

[40]  P. Wielinga,et al.  Effect of peripheral and central amylin on energy expenditure and body temperature , 2008, Appetite.

[41]  W. Banks.  The blood-brain barrier: Connecting the gut and the brain , 2008, Regulatory Peptides.

[42]  A. Jansson,et al.  Gastric emptying in response to IAPP and CCK in rats with subdiaphragmatic afferent vagotomy , 2008, Regulatory Peptides.

[43]  S. Inoue,et al.  Central and peripheral administration of amylin induces energy expenditure in anesthetized rats , 2008, Peptides.

[44]  Christian Weyer,et al.  Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies , 2008, Proceedings of the National Academy of Sciences.

[45]  N. Geary,et al.  Hindbrain administration of estradiol inhibits feeding and activates estrogen receptor-alpha-expressing cells in the nucleus tractus solitarius of ovariectomized rats. , 2008, Endocrinology.

[46]  N. Geary,et al.  Gastrointestinal Factors in Appetite and Food Intake — Animal Research , 2008 .

[47]  R. Mattes,et al.  Appetite and Food Intake : Behavioral and Physiological Considerations , 2008 .

[48]  C. Weyer,et al.  Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity. , 2007, Endocrinology.

[49]  N. Geary,et al.  Estradiol enhances cholecystokinin-dependent lipid-induced satiation and activates estrogen receptor-alpha-expressing cells in the nucleus tractus solitarius of ovariectomized rats. , 2007, Endocrinology.

[50]  K. Laugero,et al.  Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[51]  T. Lutz,et al.  Diet-Derived Nutrients Modulate the Effects of Amylin on c-Fos Expression in the Area Postrema and on Food Intake , 2007, Neuroendocrinology.

[52]  P. Wielinga,et al.  Modulation of the satiating effect of amylin by central ghrelin, leptin and insulin , 2007, Physiology & Behavior.

[53]  G. Edwards,et al.  Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK , 2007, Brain Research.

[54]  C. Weyer,et al.  Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study. , 2007, American journal of physiology. Endocrinology and metabolism.

[55]  K. Fujioka,et al.  Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study. , 2007, The Journal of clinical endocrinology and metabolism.

[56]  T. Reinehr,et al.  Amylin and Its Relation to Insulin and Lipids in Obese Children Before and After Weight Loss , 2007, Obesity.

[57]  P. Wielinga,et al.  The acute effect of amylin and salmon calcitonin on energy expenditure , 2007, Physiology & Behavior.

[58]  S. Doran,et al.  Low‐dose Pramlintide Reduced Food Intake and Meal Duration in Healthy, Normal‐Weight Subjects , 2007, Obesity.

[59]  A. Ferguson,et al.  Making Sense of It: Roles of the Sensory Circumventricular Organs in Feeding and Regulation of Energy Homeostasis , 2007, Experimental biology and medicine.

[60]  A. Young,et al.  Role of endogenous amylin in glucagon secretion and gastric emptying in rats demonstrated with the selective antagonist, AC187 , 2006, Regulatory Peptides.

[61]  C. Anderson,et al.  Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression. , 2006, Endocrinology.

[62]  T. Lutz.  Amylinergic control of food intake , 2006, Physiology and Behavior.

[63]  Satoko Nishimoto,et al.  MAPK signalling: ERK5 versus ERK1/2 , 2006, EMBO reports.

[64]  S. Woods.  Signals that influence food intake and body weight , 2005, Physiology & Behavior.

[65]  N. Geary.  A new way of looking at eating. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[66]  P. Sexton,et al.  Pharmacological Discrimination of Calcitonin Receptor: Receptor Activity-Modifying Protein Complexes , 2005, Molecular Pharmacology.

[67]  S. Doran,et al.  Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes , 2005, Diabetologia.

[68]  S. Woods,et al.  Reduced anorexic effects of insulin in obesity-prone rats fed a moderate-fat diet. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.

[69]  J. Permert,et al.  Chronically Administered Islet Amyloid Polypeptide in Rats Serves as an Adiposity Inhibitor and Regulates Energy Homeostasis , 2005, Pancreatology.

[70]  T. Lutz.  Pancreatic amylin as a centrally acting satiating hormone. , 2005, Current drug targets.

[71]  P. Wookey,et al.  Immunohistochemical mapping of calcitonin receptors in the adult rat brain , 2004, Brain Research.

[72]  H. Berthoud,et al.  Extracellular Signal-Regulated Kinase 1/2 Signaling Pathway in Solitary Nucleus Mediates Cholecystokinin-Induced Suppression of Food Intake in Rats , 2004, The Journal of Neuroscience.

[73]  P. Chelikani,et al.  Comparison of the inhibitory effects of PYY(3-36) and PYY(1-36) on gastric emptying in rats. , 2004, American Journal of Physiology. Regulatory Integrative and Comparative Physiology.

[74]  E. Nishida,et al.  Regulatory mechanisms and function of ERK MAP kinases. , 2004, Journal of biochemistry.

[75]  J. Permert,et al.  Amylin receptor blockade stimulates food intake in rats. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[76]  T. Lutz,et al.  Peptide YY Directly Inhibits Ghrelin-Activated Neurons of the Arcuate Nucleus and Reverses Fasting-Induced c-Fos Expression , 2004, Neuroendocrinology.

[77]  S. M. Robinson,et al.  Triglycerides induce leptin resistance at the blood-brain barrier. , 2004, Diabetes.

[78]  C. Weyer,et al.  Effect of pramlintide on weight in overweight and obese insulin-treated type 2 diabetes patients. , 2004, Obesity research.

[79]  T. Lutz,et al.  Infusion of the amylin antagonist AC 187 into the area postrema increases food intake in rats , 2004, Physiology & Behavior.

[80]  C. Laplace,et al.  Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo , 2004, The Journal of cell biology.

[81]  G. Rechkemmer,et al.  Peripheral amylin activates circumventricular organs expressing calcitonin receptor a/b subtypes and receptor-activity modifying proteins in the rat , 2004, Brain Research.

[82]  G. Barsh,et al.  Is the energy homeostasis system inherently biased toward weight gain? , 2003, Diabetes.

[83]  E. Scharrer,et al.  Endogenous amylin contributes to the anorectic effects of cholecystokinin and bombesin , 2003, Peptides.

[84]  T. Lutz,et al.  Histamine H1 receptors in the ventromedial hypothalamus mediate the anorectic action of the pancreatic hormone amylin , 2003, Peptides.

[85]  N. Geary,et al.  Cyclic Estradiol Treatment Normalizes Body Weight and Restores Physiological Patterns of Spontaneous Feeding and Sexual Receptivity in Ovariectomized Rats , 2002, Hormones and Behavior.

[86]  B. Levin,et al.  Reduced central leptin sensitivity in rats with diet-induced obesity. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[87]  T. Lutz,et al.  Amylin and glucose co-activate area postrema neurons of the rat , 2002, Neuroscience Letters.

[88]  J. Buse,et al.  Amylin Replacement With Pramlintide in Type 1 and Type 2 Diabetes: A Physiological Approach to Overcome Barriers With Insulin Therapy , 2002 .

[89]  D. Johnston,et al.  Protein Kinase Modulation of Dendritic K+ Channels in Hippocampus Involves a Mitogen-Activated Protein Kinase Pathway , 2002, The Journal of Neuroscience.

[90]  R. Reidelberger,et al.  Effects of amylin-related peptides on food intake, meal patterns, and gastric emptying in rats. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[91]  T. Lutz,et al.  Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[92]  T. Moran,et al.  Within-meal gut feedback signaling , 2001, International Journal of Obesity.

[93]  E. Scharrer,et al.  Histamine H1 receptors mediate the anorectic action of the pancreatic hormone amylin. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[94]  E. Air,et al.  Inhibition of central amylin signaling increases food intake and body adiposity in rats. , 2001, Endocrinology.

[95]  A. Kelley,et al.  Amylin infusion into rat nucleus accumbens potently depresses motor activity and ingestive behavior. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[96]  S. Shimada,et al.  Expression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain. , 2001, Brain research. Molecular brain research.

[97]  C. Weyer,et al.  Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control. , 2001, Current pharmaceutical design.

[98]  W. Born,et al.  Functional relevance of G-protein-coupled-receptor-associated proteins, exemplified by receptor-activity-modifying proteins (RAMPs). , 2001, Biochemical Society transactions.

[99]  E. Scharrer,et al.  The anorectic effect of a chronic peripheral infusion of amylin is abolished in area postrema/nucleus of the solitary tract (AP/NTS) lesioned rats , 2001, International Journal of Obesity.

[100]  N. Geary,et al.  Dopamine D(2) receptors mediate amylin's acute satiety effect. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[101]  J. Permert,et al.  Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[102]  M. Karin,et al.  Mammalian MAP kinase signalling cascades , 2001, Nature.

[103]  R. Ritter,et al.  Diminished satiation in rats exposed to elevated levels of endogenous or exogenous cholecystokinin. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[104]  H. Yoshimatsu,et al.  Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice. , 2001, Diabetes.

[105]  E. Scharrer,et al.  Amylin receptors mediate the anorectic action of salmon calcitonin (sCT) , 2000, Peptides.

[106]  S. Woods,et al.  Amylin: a novel action in the brain to reduce body weight. , 2000, Endocrinology.

[107]  S. Woods,et al.  Amylin and insulin interact to reduce food intake in rats. , 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[108]  H. Yoshimatsu,et al.  Hypothalamic neuronal histamine as a target of leptin in feeding behavior. , 1999, Diabetes.

[109]  Takeshi Watanabe,et al.  Involvement of the Histaminergic System in Leptin-Induced Suppression of Food Intake , 1999, Physiology & Behavior.

[110]  W. Banks,et al.  Impaired transport of leptin across the blood-brain barrier in obesity☆ , 1999, Peptides.

[111]  A. Young,et al.  Pharmacological characterisation of amylin-related peptides activating subfornical organ neurones , 1999, Brain Research.

[112]  M Morfis,et al.  Multiple amylin receptors arise from receptor activity-modifying protein interaction with the calcitonin receptor gene product. , 1999, Molecular pharmacology.

[113]  Mihai Covasa,et al.  Reduced sensitivity to the satiation effect of intestinal oleate in rats adapted to high-fat diet. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[114]  Walter Born,et al.  An Amylin Receptor Is Revealed Following Co-Transfection of a Calcitonin Receptor with Receptor Activity Modifying Proteins-1 or -3. , 1999, Endocrinology.

[115]  N. Geary,et al.  Endogenous cholecystokinin’s satiating action increases during estrus in female rats , 1999, Peptides.

[116]  P. Westermark,et al.  Islet amyloid polypeptide and insulin relationship in a longitudinal study of the genetically obese (ob/ob) mouse. , 1999, Pancreas.

[117]  I. Macdonald,et al.  Euglycaemic hyperinsulinaemia does not affect gastric emptying in Type I and Type II diabetes mellitus , 1999, Diabetologia.

[118]  N. Geary,et al.  Behaviorally specific inhibition of sham feeding by amylin , 1998, Peptides.

[119]  R. Ritter,et al.  Rats maintained on high-fat diets exhibit reduced satiety in response to CCK and bombesin , 1998, Peptides.

[120]  T. Adrian,et al.  Sufficiency of postprandial plasma levels of islet amyloid polypeptide for suppression of feeding in rats. , 1998, American Journal of Physiology.

[121]  C. Betsholtz,et al.  Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). , 1998, Biochemical and biophysical research communications.

[122]  A. Young,et al.  Synergy between amylin and cholecystokinin for inhibition of food intake in mice , 1998, Physiology & Behavior.

[123]  M. Denaro,et al.  Roles of amylin in diabetes and in regulation of nutrient load. , 1998, Nutrition.

[124]  Melanie G. Lee,et al.  RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.

[125]  W. Banks,et al.  Differential Permeability of the Blood–Brain Barrier to Two Pancreatic Peptides: Insulin and Amylin , 1998, Peptides.

[126]  A. Young,et al.  Area postrema (AP)-lesions block the regulation of gastric emptying by amylin , 1998 .

[127]  I. Macdonald,et al.  The effect of single doses of pramlintide on gastric emptying of two meals in men with IDDM , 1998, Diabetologia.

[128]  I. Macdonald,et al.  Effect of euglycaemic hyperinsulinaemia on gastric emptying and gastrointestinal hormone responses in normal subjects , 1998, Diabetologia.

[129]  F. Ehrensperger,et al.  Lesion of the Area Postrema/Nucleus of the Solitary Tract (AP/NTS) Attenuates the Anorectic Effects of Amylin and Calcitonin Gene-Related Peptide (CGRP) in Rats , 1998, Peptides.

[130]  A. Young,et al.  Hypoglycemia Overrides Amylin-Mediated Regulation of Gastric Emptying in Rats , 1998, Diabetes.

[131]  Y. Taché,et al.  Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[132]  R. M. Gentry,et al.  Comparison of Fos induced in rat brain by GLP-1 and amylin , 1997, Regulatory Peptides.

[133]  B. Balkan,et al.  Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. , 1997, The American journal of physiology.

[134]  P. Beart,et al.  Histochemistry in rat brain and spinal cord with an antibody directed at the cholecystokininA receptor , 1997, Neuroscience Letters.

[135]  Allan E. Johnson,et al.  Cholecystokinin, dopamine D2 and N-methyl-d-aspartate binding sites in the nucleus of the solitary tract of the rat: possible relationship to ingestive behavior , 1997, Neuroscience.

[136]  J. Morley,et al.  Amylin and Food Intake in Mice: Effects on Motivation to Eat and Mechanism of Action , 1997, Pharmacology Biochemistry and Behavior.

[137]  E. Scharrer,et al.  The histaminergic, but not the serotoninergic, system mediates amylin's anorectic effect , 1996, Peptides.

[138]  Gerard P. Smith.  The direct and indirect controls of meal size , 1996, Neuroscience & Biobehavioral Reviews.

[139]  T. Adrian,et al.  Chronic infusion of islet amyloid polypeptide causes anorexia in rats. , 1996, The American journal of physiology.

[140]  G. Clementi,et al.  Amylin given by central or peripheral routes decreases gastric emptying and intestinal transit in the rat , 1996, Experientia.

[141]  E. Scharrer,et al.  Subdiaphragmatic vagotomy does not influence the anorectic effect of amylin , 1995, Peptides.

[142]  N. Geary,et al.  Amylin decreases meal size in rats , 1995, Physiology & Behavior.

[143]  W. Langhans,et al.  Hepatic portal insulin antibody infusion increases, but insulin does not alter, spontaneous meal size in rats. , 1995, The American journal of physiology.

[144]  W. Banks,et al.  Permeability of the blood-brain barrier to amylin. , 1995, Life sciences.

[145]  S. Woods,et al.  Central insulin enhances sensitivity to cholecystokinin , 1995, Physiology & Behavior.

[146]  E. Stricker,et al.  Cholecystokinin activates catecholaminergic neurons in the caudal medulla that innervate the paraventricular nucleus of the hypothalamus in rats , 1995, The Journal of comparative neurology.

[147]  W. Born,et al.  Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions. , 1995, European journal of endocrinology.

[148]  T. Rink,et al.  Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin , 1995, Diabetologia.

[149]  S. Woods,et al.  Intraventricular insulin and the level of maintained body weight in rats. , 1995, Behavioral neuroscience.

[150]  T. Curran,et al.  Fos: an immediate-early transcription factor in neurons. , 1995, Journal of neurobiology.

[151]  G. Paxinos,et al.  In vitro autoradiographic localization of amylin binding sites in rat brain , 1994, Neuroscience.

[152]  Y. Lee,et al.  Direct plasma radioimmunoassay for rat amylin-(1-37): concentrations with acquired and genetic obesity. , 1994, The American journal of physiology.

[153]  J. Dunn,et al.  Manipulation of central nervous system histamine or histaminergic receptors (H1) affects food intake in rats. , 1994, The Journal of nutrition.

[154]  M. Horowitz,et al.  Modulation of food intake by peripherally administered amylin. , 1994, The American journal of physiology.

[155]  E. Scharrer,et al.  Reduction of food intake in rats by intraperitoneal injection of low doses of amylin , 1994, Physiology & Behavior.

[156]  J. Clore,et al.  Amylin/insulin secretory ratios in morbidly obese man: inverse relationship with glucose disappearance rate. , 1994, The Journal of clinical endocrinology and metabolism.

[157]  G. Cooper.  Amylin compared with calcitonin gene-related peptide: structure, biology, and relevance to metabolic disease. , 1994, Endocrine reviews.

[158]  P. McHugh,et al.  Gastric loads and cholecystokinin synergistically stimulate rat gastric vagal afferents. , 1993, The American journal of physiology.

[159]  R. Unger,et al.  Amylin-insulin relationships in insulin resistance with and without diabetic hyperglycemia. , 1993, The American journal of physiology.

[160]  H. Yoshimatsu,et al.  Zucker obese rats: defect in brain histamine control of feeding , 1992, Brain Research.

[161]  P. McHugh,et al.  Integration of vagal afferent responses to gastric loads and cholecystokinin in rats. , 1991, The American journal of physiology.

[162]  R. Rizza,et al.  Effects of Meal Ingestion on Plasma Amylin Concentration in NIDDM and Nondiabetic Humans , 1990, Diabetes.

[163]  R. Unger,et al.  Amylin secretion from the rat pancreas and its selective loss after streptozotocin treatment. , 1990, The Journal of clinical investigation.

[164]  H. Yoshimatsu,et al.  Modulation of neuronal histamine in control of food intake , 1988, Physiology & Behavior.

[165]  H. Yoshimatsu,et al.  Feeding induced by blockade of histamine H1-receptor in rat brain , 1988, Experientia.

[166]  J. Schwartz,et al.  Highly potent and selective ligands for histamine H3-receptors , 1987, Nature.

[167]  S. Woods,et al.  Cholecystokinin persistently suppresses meal size but not food intake in free-feeding rats. , 1984, The American journal of physiology.

[168]  J. Crawley,et al.  Rapid development of tolerance to the behavioural actions of cholecystokinin , 1983, Nature.

[169]  M. Ashwell,et al.  Obesity: Do fat cells from genetically obese mice (C57BL/6J ob/ob) have an innate capacity for increased fat storage? , 1978, Diabetologia.

[170]  J. Le Magnen,et al.  Eating as a regulatory control of drinking in the rat. , 1969, Journal of comparative and physiological psychology.

[171]  H. Munzberg.  Leptin-signaling pathways and leptin resistance. , 2010, Forum of nutrition.

[172]  J. Chen,et al.  Fatty acids induce amylin expression and secretion by pancreatic beta-cells. , 2010, American journal of physiology. Endocrinology and metabolism.

[173]  D. Parkes,et al.  Mechanisms of amylin/leptin synergy in rodent models. , 2010, Endocrinology.

[174]  William A Banks,et al.  Blood-brain barrier as a regulatory interface. , 2010, Forum of nutrition.

[175]  N. Geary,et al.  Gastrointestinal Factors in Appetite and Food Intake , 2008 .

[176]  S. Bloom,et al.  Gastrointestinal satiety signals. , 2008, Annual review of physiology.

[177]  C. Anderson,et al.  Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression. , 2006, Endocrinology.

[178]  A. Young.  Inhibition of gastric emptying. , 2005, Advances in pharmacology.

[179]  S. Woods.  Gastrointestinal satiety signals I. An overview of gastrointestinal signals that influence food intake. , 2004, American journal of physiology. Gastrointestinal and liver physiology.

[180]  T. Lutz,et al.  The anorectic hormone amylin contributes to feeding-related changes of neuronal activity in key structures of the gut-brain axis. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.

[181]  B. Levin,et al.  Defense of body weight depends on dietary composition and palatability in rats with diet-induced obesity. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.

[182]  W. A. Banks,et al.  Leptin transport across the blood-brain barrier: implications for the cause and treatment of obesity. , 2001, Current pharmaceutical design.

[183]  B. Levin,et al.  Defense of body weight against chronic caloric restriction in obesity-prone and -resistant rats. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[184]  E. Scharrer,et al.  Anorectic effect of amylin is not transmitted by capsaicin-sensitive nerve fibers. , 1998, The American journal of physiology.

[185]  I. Macdonald,et al.  Infusion of pramlintide, a human amylin analogue, delays gastric emptying in men with IDDM , 1997, Diabetologia.

[186]  T. Rink,et al.  Dose-response for glucagonostatic effect of amylin in rats. , 1997, Metabolism: clinical and experimental.

[187]  C. Plata-salamán.  Hypothalamic Neuronal Histamine: Implications of its Homeostatic Control of Energy Metabolism , 1997 .

[188]  T. Rink,et al.  Dose-responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36) NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake. , 1996, Metabolism: clinical and experimental.

[189]  T. Sanke,et al.  Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus. , 1992, Diabetes research and clinical practice.

[190]  M. Nakazato,et al.  Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus. , 1992, Diabetes research and clinical practice.

[191]  J. Schwartz,et al.  Histaminergic transmission in the mammalian brain. , 1991, Physiological reviews.